| Title | A Study to Assess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma Patients |
|---|---|
| Description | Randomised, double-blind, parallel group study to compare PK and PD profiles between IBI301 and rituximab in patients with CD20+ B-cell Lymphoma |
| Organism | Homo sapiens |
| Data Type | Clinical Research data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA015681 |
| Release Date | 2024-12-31 |
| Submitter | li pu (pu.li@innoventbio.com) |
| Organization | Innovent Biologics (Suzhou) Co., Ltd. |
| Submission Date | 2023-03-21 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX003420-01 | CIBI301A201 rawdata20190325 | 228 | Clinical Research data | 3.8 MB | rar | Controlled |
| OMIX003420-02 | CIBI301A201_PK data | 179 | Clinical Research data | 111.6 KB | csv | Controlled |
| OMIX003420-04 | CIBI301A201 ADA data | 219 | Clinical Research data | 76.8 KB | xlsx | Controlled |
| OMIX003420-05 | CIBI301A201_blood concentration data | 181 | Clinical Research data | 390.5 KB | xls | Controlled |
| OMIX003420-06 | CIBI301A201 PD data | 181 | Clinical Research data | 2.1 MB | xls | Controlled |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|